In a highly unusual move, CDC Director Rochelle Walensky, MD, overruled the agency’s panel of experts, saying that health care workers should get COVID-19 booster shots.
Rochelle Walensky, MD, the director of the Centers for Disease Control and Prevention (CDC), in the early hours today overruled a CDC advisory panel’s decision to deny COVID-19 booster shots to health care workers and other frontline workers. In doing so, Walensky rejected a decision made by her own panel of experts—the CDC’s Advisory Committee on Immunization Practices (ACIP)—who earlier yesterday said health care workers shouldn’t get the Pfizer/BioNTech booster shots. Instead, Walensky sided with an expert panel working for the Food and Drug Administration (FDA) that said on Wednesday that health care workers should be included.
Walensky said in a statement issued shortly after midnight that “I believe we can best serve the nation’s public health needs by providing booster doses for the elderly, those in long-term care facilities, people with underlying medical conditions, and for adults at high risk of disease from occupational and institutional exposures to COVID-19. This aligns with the FDA's booster authorization and makes these groups eligible for a booster shot.”
The CDC did suggest that booster shots be made available to:
That differs only slightly from what the FDA panel said on Wednesday. The FDA panel said that the booster shots should be made available to:
Walensky said in her statement that “as CDC Director, it is my job to recognize where our actions can have the greatest impact. At CDC, we are tasked with analyzing complex, often imperfect data to make concrete recommendations that optimize health. In a pandemic, even with uncertainty, we must take actions that we anticipate will do the greatest good.”
Walensky’s statement echoes the statement issued Wednesday by Acting FDA Commissioner Janet Woodcock, MD. Woodcock said that “after considering the totality of the available scientific evidence and the deliberations of our advisory committee of independent, external experts, the FDA amended the EUA [emergency use authorization] for the Pfizer-BioNTech COVID-19 Vaccine to allow for a booster dose in certain populations such as health care workers, teachers and day care staff, grocery workers and those in homeless shelters or prisons, among others.”
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies